Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma (NCT04525209) | Ruijin Hospital | 2020-10-01 |
Track Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics automatically
Every clearance here is in the API, with alerts when new ones post.